KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Receivables (2016 - 2025)

Elevance Health (ELV) has disclosed Receivables for 17 consecutive years, with $17.2 billion as the latest value for Q3 2025.

  • On a quarterly basis, Receivables rose 29.88% to $17.2 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $17.2 billion, a 29.88% increase, with the full-year FY2024 number at $14.0 billion, up 5.41% from a year prior.
  • Receivables was $17.2 billion for Q3 2025 at Elevance Health, down from $17.7 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $17.7 billion in Q2 2025 to a low of $7.2 billion in Q4 2021.
  • A 5-year average of $12.5 billion and a median of $12.9 billion in 2023 define the central range for Receivables.
  • Peak YoY movement for Receivables: fell 11.44% in 2021, then surged 58.49% in 2022.
  • Elevance Health's Receivables stood at $7.2 billion in 2021, then soared by 58.49% to $11.4 billion in 2022, then rose by 16.92% to $13.3 billion in 2023, then grew by 5.41% to $14.0 billion in 2024, then rose by 22.81% to $17.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Receivables are $17.2 billion (Q3 2025), $17.7 billion (Q2 2025), and $16.9 billion (Q1 2025).